BS
BioNTech SE
🇩🇪XFRA.22UAGermanyHealthcare
€83.85EURdown -2.70 (-3.12%)OpenEnd of day3:31 PM
Price€83.85-2.70 (-3.12%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US09075V1026
- CUSIP
- Not reported
Company
- Employees
- 7,807
- Headquarters
- Mainz, United States
- Website
- https://www.biontech.de
- CEO
- Dr. Ugur Sahin M.D.
Market
- Shares outstanding
- 251.2M
- Market cap
- €21.06B
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- €21.06B
- EPS LTM
- -€6.66
- P/E LTM
- -12.36
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- €2.65B-7.93%down year on year
- Net income
- -€1.69B-389.1%down year on year
- Gross margin
- 75.47%-5.38%down year on year
- Free cash flow
- €444.7M+117.38%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.